Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial
- PMID: 19171735
- PMCID: PMC2628683
- DOI: 10.2337/dc08-1153
Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial
Abstract
Objective: Diabetes is associated with cognitive decline and dementia. However, the relationship between the degree of hyperglycemia and cognitive status remains unclear. This was explored using baseline cognitive measures collected in the ongoing Memory in Diabetes (MIND) substudy of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Research design and methods: The relationship of A1C and fasting plasma glucose (FPG) levels to performance on four cognitive tests was assessed, adjusting for age and other determinants of cognitive status. The tests were the Digit Symbol Substitution Test (DSST), Mini Mental Status Examination (MMSE), Rey Auditory Verbal Learning Test, and Stroop Test.
Results: A statistically significant age-adjusted association was observed between the A1C level and the score on all four cognitive tests. Specifically, a 1% higher A1C value was associated with a significant 1.75-point lower DSST score (95% CI -1.22 to -2.28; P < 0.0001), a 0.20-point lower MMSE score (-0.11 to -0.28; P < 0.0001), a 0.11-point lower memory score (-0.02 to -0.19, P = 0.0142), and a worse score (i.e., 0.75 s more) on the Stroop Test (1.31-0.19, P = 0.0094). The association between the DSST score and A1C persisted in all multiple linear regression models. FPG was not associated with test performance.
Conclusions: Higher A1C levels are associated with lower cognitive function in individuals with diabetes. The effect of glucose lowering on cognitive function will be determined by the ongoing ACCORD-MIND trial.
Figures
Comment in
-
Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial: response to Cukierman-Yaffe et al.Diabetes Care. 2009 Aug;32(8):e102; author reply e103. doi: 10.2337/dc09-0658. Diabetes Care. 2009. PMID: 19638518 No abstract available.
References
-
- Glasgow RE, Fisher L, Skaff M, Mullan J, Toobert DJ: Problem solving and diabetes self-management: investigation in a large, multiracial sample. Diabetes Care 30:33–37, 2007 - PubMed
-
- Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G: Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc 51:410–414, 2003 - PubMed
-
- Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R: Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154:635–641, 2001 - PubMed
-
- MacKnight C, Rockwood K, Awalt E, McDowell I: Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14:77–83, 2002 - PubMed
-
- Peila R, Rodriguez BL, Launer LJ, Honolulu-Asia AS: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51:1256–1262, 2002 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01 HC095179/HL/NHLBI NIH HHS/United States
- N01 HC095184/HL/NHLBI NIH HHS/United States
- Y1-HC-9035/HC/NHLBI NIH HHS/United States
- N01-HC-95180/HC/NHLBI NIH HHS/United States
- N01 HC095178/HL/NHLBI NIH HHS/United States
- Y1-HC-1010/HC/NHLBI NIH HHS/United States
- N01-HC-95184/HC/NHLBI NIH HHS/United States
- N01 HC095182/HL/NHLBI NIH HHS/United States
- U10 NS086728/NS/NINDS NIH HHS/United States
- N01-HC-95179/HC/NHLBI NIH HHS/United States
- N01-HC95178/HC/NHLBI NIH HHS/United States
- N01 HC095180/HL/NHLBI NIH HHS/United States
- Y01 HC001010/HC/NHLBI NIH HHS/United States
- Y01 HC009035/HC/NHLBI NIH HHS/United States
- N01 HC095181/HL/NHLBI NIH HHS/United States
- N01-HC-95182/HC/NHLBI NIH HHS/United States
- N01 HC095183/HL/NHLBI NIH HHS/United States
- N01-HC-95183/HC/NHLBI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- HC-99-16/HC/NHLBI NIH HHS/United States
- N01-HC-95181/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
